CardiacSense is a dynamic digital health company that has developed best-in class, wearable sensor technology with the sensitivity and specificity required for medical diagnosis and monitoring.
CardiacSense develops wearable equipment (watches, bracelets, patches, etc.) which includes a number of highly advanced state of the art sensors, based on the illumination the body, processing the returns, and analysis using a unique algorithm.
The development is focused on a clinically-proven medical solution that delivers reliable cardiac and blood pressure monitoring, 24/365, for as long as needed.
The initial focus is on monitoring and detection of atrial fibrillation, CardiacSense received CE clearance for AF detection and expects FDA clearance for AF detection by the end of 2021 .
Clinical studies demonstrated the accuracy of the CardiacSense algorithm: 99% sensitivity and 99% specificity in distinguishing atrial fibrillation (AF) from sinus rhythm.
Several other near-term applications are in development, including monitoring of other arrythmias and vital signs such as blood pressure, respiratory rate, and oxygen saturation.